A Study of JNJ-90009530 in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (r/r B-NHL) | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of JNJ-90009530 in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (r/r B-NHL)	B-cell neoplasm, Disease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm	Active, not recruiting	Phase 1	2026-09-25		NCT05784441

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Janssen Research & Development, LLC	188

15 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Austin Hospital	Heidelberg	Australia	11
Hadassah Medical Center	Jerusalem	Israel	50
Mayo Clinic Rochester	Rochester	United States	133
MD Anderson Cancer Center	Houston	United States	589
Monash Medical Centre	Clayton	Australia	16
Royal Brisbane and Women's Hospital	Herston	Australia	8
Royal Prince Alfred Hospital	Camperdown	Australia	19
Rutgers University	New Brunswick	United States	12
Sheba Medical Center	Ramat Gan	Israel	7
University College London Hospitals	London	United Kingdom	7
University Hospitals Cleveland Medical Center	Cleveland	United States	234
University of Iowa Hospital	Iowa City	United States	5
University of Kentucky	Lexington	United States	65
University of Pennsylvania	Philadelphia	United States	507
Westmead Hospital	Westmead	Australia	23